1. Coltman CA: Chemotherapy of advanced Hodgkin’s disease. Semin Oncol 7:155–173, 1980.
2. Goodman LS, Wintrobe MM, Dameshek W, et al.: Nitrogen mustard therapy. JAMA 132:126–132, 1946.
3. Karnofsky DA, Craver LF, Rhoads CP, Abels JC: An evaluation of methyl-bis-(B-chloroethyl)amine hydrochloride and tris-(B-chloroethyl)amine hydrochloride (nitrogen mustards) in the treatment of lymphomas, leukemia, and allied diseases. In: Approaches to tumor chemotherapy. Washington, DC: Am Assoc for the Advancement of Science, 1947, pp 319–337.
4. Zanes RP, Doan CA, Hoster HA: Studies in Hodgkin’s syndrome. VII. Nitrogen mustard therapy. J Lab Clin Med 33:1002–1018, 1948.
5. Carter SK, Livingston RB: Single-agent therapy for Hodgkin’s disease. Arch Intern Med 131:377–387, 1973.